Internet Activities

Paradigm has experience in the customized design of interactive web portals that provide learners with CME-certified, on-demand activities, many of which are a core component of our multi-platform initiatives. These web sites incorporate online registration for upcoming live events, host enduring activities for up to 2 years, and make available additional educational tools and references. Below are a few samples of our more recent sites.
 

UNCOVERING THE NUANCES OF ORAL ANTICOAGULATION FOR OPTIMAL MANAGEMENT OF HOSPITALIZED PATIENTS

During this CME-certified symposium, expert faculty will provide guidance - via didactic lecture and interactive case studies - on how to identify at-risk patients who are candidates for oral anticoagulation therapy in the hospital setting. Through the use of iPad technology to enhance the learning experience, participants will be provided with evidenced-based information allowing for differentiating among the oral anticoagulants, selecting the most appropriate oral anticoagulant for at-risk patients based on individual drug and patient characteristics; and understanding strategies for stopping and reinitiating anticoagulation in patients undergoing surgical procedures.

 

NONWARFARIN ORAL ANTICOAGULANTS (NOACS): THE CLINICAL PHARMACIST'S PERSPECTIVE

Few topics are as relevant - or of as intense interest - to contemporary pharmacy practice as the appropriate use of nonwarfarin oral anticoagulants (NOACs) approved by the FDA in January 2015. NOACs offer distinct advantages over warfarin; they have a rapid onset of action, more predictable pharmacologic profiles, and significantly reduced food and drug interactions. This activity offers education for clinical pharmacists on the latest evidence surrounding the different indications for NOACs, proper dosing strategies, management of bleeding, counseling patients on the safe use of NOACs (and how they differ from warfarin), managing and monitoring for food-drug and drug-drug interactions, and managing care transitions.

 

Updates in Chemotherapy-Induced Nausea and Vomiting: The Oncology Nurse and Oncology Nurse Practitioner's Perspectives

Chemotherapy-induced nausea and vomiting (CINV) is a highly debilitating side effect of chemotherapy. CINV is common, causing symptoms in up to 30% of all patients who undergo chemotherapy, and occurring in up to 90% of patients who receive highly emetogenic agents such as cisplatin-, doxorubicin-, and cyclophosphamide-containing regimens. The American Society of Clinical Oncology (ASCO) voted modern antiemetic therapy as one of the top 10 advances in modern oncology because antiemetic therapy is an advance that marked one of the "major turning points for cancer care and improved and saved the lives of countless Americans." In this interactive video webinar advanced practice oncology NPs and oncology RNs share and discuss their extensive and unique experiences in managing patients suffering from or at risk of developing CINV, including nuances of antiemetic agents and experiential strategies for positioning antiemetic therapies, as well as how to educate patients regarding CINV and its prevention and treatment.

 

NEW APPROACH TO LYMPHOMAS: TARGETING CD30

Targeted agents for the treatment of CD30-expressing lymphomas, including Hodgkin lymphoma and systemic and cutaneous T-cell lymphomas, has entered the clinic with several strategies in late-stage clinical trials. However, there is a lack of knowledge of how to best manage patients with CD30-expressing lymphoma based on disease characteristics and new treatment approaches. This monograph includes an in-depth discussion of the current and emerging treatment of CD30-expressing lymphomas. In addition, the mechanism of action of the antibody-drug conjugate, brentuximab vedotin, and management considerations of patients taking brentuximab vedotin will be explored with commentary from experts in the field of lymphoma.

 

CONSIDERATIONS IN THE CLINICAL USE OF NON-WARFARIN ORAL ANTICOAGULATION IN THROMBOSIS

Nonwarfarin oral anticoagulants (NOACs) have emerged as key therapies to prevent and/or treat potentially deadly thrombotic conditions including stroke or systemic embolic events in patients with nonvalvular atrial fibrillation and venous thromboembolism. Although NOACs offer many advantages over conventional therapies, confusion over certain aspects of their safe and effective use in clinical practice persist. This educational activity will provide the latest data and recommendations in a case-based format to help guide the appropriate and confident use of NOACs in a variety of scenarios commonly encountered in clinical practice.

 

ANTICOAGULATION IN THE EMERGENCY DEPARTMENT: A CASE-BASED APPROACH TO MANAGING PATIENTS WITH VENOUS THROMBOEMBOLISM AND NONVALVULAR ATRIAL FIBRILLATION

This live, interactive continuing medical education program will review current evidence and strategies for applying the information to confidently make appropriate "real-time" patient-centered treatment decisions in the emergency department with regard to the use of oral anticoagulation, and in particular the nonwarfarin oral anticoagulants. Key information will be presented in the context of patient case scenarios with the opportunity for participants to have their questions addressed by faculty. Topics include red flags for recognition and efficient diagnosis of nonvalvular atrial fibrillation and venous thromboembolism in the emergency department, balanced risk assessment for thrombosis and bleeding, choosing among available oral anticoagulants, and new strategies for managing acute bleeding events.

 

CLINICAL PHARMACISTS AND CHRONIC HEART FAILURE: UNDERSTANDING THE ROLE OF NEW AND ESTABLISHED THERAPIES

This initiative will define chronic heart failure (CHF) with reduced ejection fraction (HFrEF or systolic HF) and will provide visual information and expert instruction to help clinical pharmacists differentiate between CHF/HFrEF and CHF with preserved ejection fraction (HFpEF, or diastolic heart failure). Faculty will review existing algorithms for the use of established cardiovascular drugs in treating CHF/HFrEF and describe the mechanisms of action, approved or proposed indications, and role of new and emerging agents in the treatment of CHF/HFrEF. The information presented will be vital to clinical pharmacists who are assuming an ever increasing role on the CHF treatment team.

 

A PATIENT-CENTERED APPROACH TO CHRONIC LYMPHOCYTIC LEUKEMIA: NEW PERSPECTIVES ON MEDICAL MANAGEMENT, QUALITY OF LIFE, AND PSYCHOSOCIAL CARE

This program reviews the diagnosis and staging of chronic lymphocytic leukemia (CLL), current practices in the pharmacotherapy of CLL, and the status of agents in development. It also describes how CLL affects patientsí and caregiversí emotional and mental well-being and takes an in-depth look at how clinicians can measure the impact of the disease on healthcare-related quality of life (HRQoL) and improve patient HRQoL.

 

RECENT ADVANCES AND EMERGING TRENDS IN ONYCHOMYCOSIS MANAGEMENT: A SERIES OF LIVE CME SATELLITE SYMPOSIA AND AN ENDURING ON-DEMAND WEBINAR

Onychomycosis - a chronic infectious disease with significant medical and psychosocial consequences - can be extremely challenging to eradicate. To manage onychomycosis effectively, clinicians need to understand the etiology, diagnosis, and management of onychomycosis as a chronic infectious disease. They must also understand the characteristics of current topical, systemic, and mechanical treatments and be able to appropriately integrate new and emerging therapies into their practice based on treatment benefits and risks and patient factors. This initiative was designed to educate dermatologic clinicians on recent advances and emerging trends in onychomycosis management based on evidence from clinical trials, data on newer antifungal agents, and expert opinion and recommendations.

 

ADVANCES IN ATOPIC DERMATITIS: EXPERT INSIGHTS INTO NEW AND EMERGING THERAPIES

Atopic dermatitis (AD) is a chronic, inflammatory, relapsing disorder that can result from a number of different factors including genetics, immune system dysfunction, and possibly environmental exposures. Because there is no known cure, treating patients with AD can be challenging and often frustrating for both the clinician and the patient. This CME provides information on the role of immune abnormalities and skin-barrier dysfunction in the development of AD and how this understanding informs and can help guide treatment selection. Expert faculty will discuss the 2014 AAD guidelines and other recent guidelines for diagnosis and management of AD, and summarize data on current and emerging topical and systemic therapies to help providers optimize treatment outcomes.

 

ADVANCING THE CARE OF POST-ACNE SCARRING: EXPERT INSIGHTS INTO NEW TREATMENT OPTIONS.

Optimal management of patients with atrophic facial scars of acne vulgaris requires mindfulness of the patient's psychosocial burden; familiarity with the latest evidence-based data on efficacy and safety of available treatment modalities; and the ability to match a patient's skin type, unique scar formation, and desired outcomes with the most appropriate treatment. During this CME-accredited activity, a panel of experts will address barriers to optimal treatment through presentations integrating didactic content with video case studies that include relevant demonstrations of patient assessment and treatment.

 

TYPE 2 DIABETES MANAGEMENT: CURRENT GUIDELINES AND DECIPHERING THE LATEST THERAPY OPTIONS.

An individualized approach to management of type 2 diabetes mellitus (T2DM) may be the most likely tactic for achieving the best outcomes for any given T2DM patient, but it poses a challenge to clinicians with limited time and resources, especially given the ever-expanding armamentarium of antidiabetic drugs - including the incretin-based classes (GLP-1 receptor agonists and DPP-4 inhibitors), SGLT2 inhibitors, and combination agents. This CME-certified web monograph, which includes faculty audio clips and interactive questions, was designed to help guide appropriate treatment selection based on the T2DM patient's clinical characteristics, therapeutic goals, and patient's preference.

 

TRUST YOUR GUT: IMPROVING THE PHYSICIAN ASSISTANTíS ACUMEN IN IDENTIFYING AND MANAGING IRRITABLE BOWEL SYNDROME AND CHRONIC IDIOPATHIC CONSTIPATION

Using a combination of didactic text, realistic case studies, interactive questions, and audio clips voicing the perspectives of our diverse PA, gastroenterologist, and patient faculty, this web monograph will immerse PAs in current, evidence-based approaches to identifying and managing IBS and CIC and provide strategies for improved patient-clinician communication≠widely recognized as a cornerstone of optimal care. Knowledge of these advances, coupled with the patient-centered care PAs are known for, has the potential to greatly elevate both health outcomes and patient satisfaction.

 

DUAL ORAL ANTIPLATELET THERAPY FOR ACS: IMPROVING STANDARDS OF CARE TO OPTIMIZE OUTCOMES

This live CME-certified symposium at the AHA Scientific Sessions 2014 was designed for cardiologists and interventional cardiologists, primary care physicians, hospitalists, fellows, PAs, NPs, and other healthcare providers caring for patients with ACS. It reviewed the latest guidelines for dual oral antiplatelet therapy for patients presenting with ACS and described recent data on these therapies in patients with UA/NSTEMI and STEMI.

Based on the live presentation, the CME/CE-certified enduring webinar is intended for cardiologists, interventional cardiologists, emergency department physicians, primary care physicians, hospitalists, fellows, PAs, NPs, and other healthcare professionals caring for or interested in the management of patients with ACS.

 

SHARPENING FIBROMYALGIA DIAGNOSIS AND MANAGEMENT SKILLS: IMPROVING THE PATIENT EXPERIENCE

This CME/CE-certified, on-demand webinar was designed for primary care practitioners and other clinicians who manage patients with fibromyalgia. During the presentation, 2 expert clinicians, a patient with fibromyalgia, and a representative of a fibromyalgia patient advocacy group discuss and debate criteria that suggest a diagnosis of fibromyalgia, evidence-based pharmacologic and nonpharmacologic treatment strategies, and communication strategies to improve active listening and foster and open dialogue with these patients.

 

IMPROVING PATIENT CARE: NEW DIAGNOSTIC TECHNOLOGY FOR RAPID DETECTION OF COMMON INFECTIOUS DIARRHEAL AGENTS

This interactive, enduring CME-certified webinar - presented by 3 expert faculty, a gastroenterologist, an infectious disease specialist, and a microbiologist - was designed to increase clinician awareness of new same-day, single-specimen diagnostic assays. It enabled clinicians to identify patients who are candidates for testing and interpret test results according to assay performance characteristics and limitations.

 

THE EVOLVING ROLE OF BETA BLOCKERS IN THE MANAGEMENT OF HYPERTENSION: EXPERT PERSPECTIVES

This CME-certified, enduring on-demand webinar was comprised of short didactic presentations and an extended roundtable discussion among presenters. The webinar, hosted by Paradigm, was promoted via several mechanisms, including a robust email campaign to Paradigm's growing internal database of learners, and distributed through PeerAudience's OpenCME Network.

 

HYPONATREMIACME.ORG

This interactive website, dedicated to providing continuing education for physicians and other healthcare providers on the management of hyponatremia, includes case-based interactive webinars, text-based learning modules, and other online learning tools.

 

THE INFECTIOUS DISEASE SPECIALIST AS THE CATALYST FOR INFORMED ANTI-INFECTIVE DECISION MAKING IN THE HOSPITAL SETTING: FOCUS ON CABP AND ABSSSI

This live, interactive, case-based CME symposium following the Official Programming of the 49th Annual Meeting of the IDSA was videotaped and then developed into an interactive on-demand webinar hosted on Paradigm's website. Both activities presented vital information on the optimal management of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections in the hospital setting, with particular attention to the role of new anti-infective agents.

 

CORE STRATEGIES FOR MANAGING CABP: OPTIMIZING CLINICAL RESOURCES AND EVIDENCE TO MEET JOINT COMMISSION/CMS QUALITY MEASURES

This case-based CME webcast was launched in May 2012. The Q&A Session consisted of questions identified by the faculty as well as pertinent questions from previous programs on CABP. The webcast was hosted and distributed on the Paradigm website and distributed via a number of methods including CECity's Centricity Distribution Network.

 

THE ROLE OF THE CLINICAL PHARMACIST AS A CATALYST FOR APPROPRIATE ANTIBIOTIC DECISION-MAKING IN 2012 AND BEYOND: FOCUS ON CABP AND ABSSSI

This live, case-enhanced, audience-interactive CME satellite symposium at the ACCP 2012 Annual Meeting was targeted to clinical pharmacists. An enduring, case-enhanced, interactive web monograph, developed based on the live symposium, was hosted and distributed by Power-Pak C.E.

 

COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA: INPATIENT STRATEGY FOR HOSPITALISTS

This live, CME-certified, case-based, interactive satellite symposium at the SHM's 2013 Annual Meeting included challenging real-world clinical cases interspersed with didactic lectures and audience participation technology. The enduring, on-demand web activity, featuring an interactive text-based format of faculty presentations and discussions, was based on the proceedings of the live symposium. The enduring activity was hosted on The Hospitalist's website, www.the-hospitalist.org (an official website of the SHM), and cross-linked to www.paradigmmc.com.

 

OUT WITH THE OLD? IN WITH THE NEW? BAD BUGS, NEW DRUGS, AND ANTIMICROBIAL STEWARDSHIP

This live, interactive CME satellite symposium, presented at IDWeek™ 2014, included didactic lectures and in-depth moderated Q&A between attendees and faculty focusing on optimal treatment strategies for the management of hospital-acquired infections frequently associated with MDROs and new and emerging treatment aligned with the tenets of antimicrobial stewardship. The enduring web monograph, developed from the proceedings of the live symposium, was hosted on the Paradigm website, www.paradigmmc.com, and distributed via Paradigm and Elsevier on the MEDLINE-indexed American Journal of Infection Control website, as well as other appropriate web portals.

 

WHY CARE ABOUT SEASONAL INFLUENZA IN THE AGE OF EBOLA?

This enduring CME web monograph, developed by Paradigm and Global Education Group, provides clinicians with evidence-based faculty discussion to help them better understand the virus and learn about high risk populations, influenza-associated complications, prevention, and treatment. Available through February 2016 at www.paradigmmc.com/a396e, the activity is designed for physicians, nurses, NPs, PAs, and other clinicians who care for patients with chronic diseases who may be at high risk for consequences of seasonal influenza.

 

EPISODIC AND CHRONIC MIGRAINE HEADACHE: BREAKING DOWN BARRIERS TO OPTIMAL TREATMENT AND PREVENTION

This CME initiative, led by 2 experts with clinical expertise in migraine management, includes a print and online supplement to Headache: The Journal of Head and Face Pain, the official journal of the American Headache Society. The 16-page print version was polybagged and distributed to all subscribers along with a monthly issue. The online version, converted into an interactive web monograph, includes hyperlinks to video vignettes and other important references and resources. The online version was posted on www.headachejournal.org and the neurology portal of www.paradigmmc.com.

 

EPISODIC AND CHRONIC MIGRAINE HEADACHES: TRANSFORMING SCIENCE INTO CLINICAL SUCCESS

This case-based, on-demand webinar discusses differential diagnosis, proper utilization of the latest guidelines and new agents in the treatment of migraine. It incorporates didactic presentation, video lecture, and case-enhanced vignettes with embedded videos to illustrate unique delivery systems and management techniques. The webinar is hosted on Paradigm's website, www.paradigmmc.com, and distributed via myCME. The live portion of this activity includes a series of meetings with didactic lecture, real-world case studies, and a hands-on workshop focusing on therapies with unique delivery systems.

 

A MEN'S HEALTH INITIATIVE: FOCUS ON MALE HYPOGONADISM AND TESTOSTERONE REPLACEMENT THERAPY

This enduring, CME-certified web monograph was branded by Urology ("The Gold Journal") and hosted on www.goldjournal.net. The web monograph was MEDLINE-indexed and distributed by Elsevier via email blasts, print and banner ads to their mix of Urology and Internal Medicine Journals. The webinar was followed by a live CME-certified satellite symposium, held in conjunction with the Southeast Section meeting of the AUA in March 2014.

 

MULTIDISCIPLINARY APPROACH TO CHARTING A TREATMENT COURSE FOR MEN WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: A CASE CONSULTS™ WEB ACTIVITY

This CME/CE-certified Case Consults™ video webinar includes a short overview discussion among the multidisciplinary faculty about the challenges in treating mCRPC followed by interactive patient cases. Designed to increase participant ability to apply a comprehensive set of monitoring parameters and make rational, evidence-based treatment decisions for their patients with metastatic castration-resistant prostate cancer based on current clinical evidence and guidelines, the activity is accessible via the Paradigm website, www.paradigmmc.com; the University of Cincinnati's CME website, www.cme.uc.edu; and the myCME website, www.myCME.com.

 

ADVANCING THE TREATMENT STRATEGIES IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: THE UROLOGIST'S ROLE

This text-based, interactive, CME-certified web monograph features audio and video clips of expert faculty interviews and discussions and was designed to provide urologists, medical and radiation oncologists, and other healthcare professionals with the latest information on monitoring parameters that may help guide treatment decisions or indicate efficacy of therapy. The faculty also provide information on differences among available therapies to facilitate evidence-based, individualized treatment decisions and the roles of multidisciplinary team members in managing mCRPC patients.

 

MELANOMACARE.ORG

This interactive website served as the platform for the many components of the Melanoma Care Coalition, an award-winning, comprehensive, multidisciplinary educational initiative designed for medical oncologists, surgical oncologists, dermatologists, oncology nurses, and other healthcare professionals caring for patients with melanoma. This initiative was developed and implemented in collaboration with the University of Pittsburgh School of Medicine.

 

2012 MELANOMA CARE COALITION WEBINAR SERIES

This series of CME/CNE-certified on-demand-webinars, available at www.melanomacare.org, focused on the pivotal issues that clinicians face in the care of patients with melanoma, such as advances in immunotherapy, management of metastatic melanoma, chemotherapy of melanoma, updates on emerging therapies, management, and biomarkers of melanoma.

 

DIABETIC RETINOPATHY AND RELATED EYE DISORDERS: NEW DEVELOPMENTS IN DIAGNOSIS AND TREATMENT

This text-based, case-enhanced, interactive, CME-certified web monograph includes links to relevant audio clips derived from a recorded faculty teleconference. It is hosted on the Paradigm website, www.paradigmmc.com and is also being distributed via Healio's Ophthalmology and Optometry websites, www.healio.com/ophthalmology, online home of Ophthalmic Surgery, Lasers and Imaging, Retina and Ocular Surgery News, and www.healio.com/optometry.

 

CLARIFYING THE ROLE OF NOVEL AND EMERGING TREATMENTS FOR DIABETIC RETINOPATHY AND RELATED EYE DISORDERS

This live, interactive, CME-certified symposium will be held at the AAO 2015 Annual Meeting, November 14-17, 2015 and will incorporate didactic lectures, interactive patient case studies, videos of injection techniques, and in-depth moderated Q&A between attendees and faculty. Throughout the symposium, attendees will use iPads, provided by Educational Measures, to view the program, take notes, and interact with faculty. An enduring, text-based, interactive web monograph, including links to relevant audio and video from the live ancillary symposium, will be hosted on the Paradigm website, www.paradigmmc.com, and distributed via Paradigm as well as Healio's Ophthalmology Education Lab website, www.healio.com/ophthalmology, online home of Ophthalmic Surgery, Lasers and Imaging and Retina and Ocular Surgery News.

 

INDIVIDUALIZED TREATMENT OF DIABETIC RETINOPATHY AND DIABETIC MACULAR EDEMA: A CASE-BASED GUIDE TO APPLYING NEW DATA

This series of 3 Case Consults™ CME Web Activities offers a serial learning design consisting of 3 digitally-delivered quarter-hour case activities designed to enhance clinical skill development of retina specialists managing DR and DME. Using the RealCME platform, each activity will utilize text, faculty audio clips, dynamic tools for interdisciplinary communication, and instructional intravitreal injection videos to guide learners through interactive patient case studies, where they will be required to respond to questions at critical decision points in the course of treatment. This web initiative will be distributed by Paradigm and PeerAudience's OpenCME Network.

 

CHRONIC OBSTRUCTIVE PULMONARY DISEASE: ENHANCING THE BREADTH OF OUTPATIENT CARE FROM DIAGNOSIS THROUGH MANAGEMENT

This CME/CE-certified webinar features short didactic presentations followed by extended roundtable discussions among experts in the field of pulmonary medicine, geared toward the office-based practitioner (PCPs, PAs, NPs, and community pulmonologists). In addition, a demonstration of the appropriate use of currently available COPD management agents and equipment is available for clinician/patient viewing, along with other clinician and patient education tools. The webinar, hosted by Paradigm, was promoted via several mechanisms, including a robust email campaign to Paradigm's internal database of learners, and distribution through PeerAudience's OpenCME Network.

 

CHRONIC OBSTRUCTIVE PULMONARY DISEASE: IMPROVING CARE AND PATIENT OUTCOMES

COPD is placing a strain on health care systems nationwide. One reason is that exacerbations of COPD are all too common, leading to excessive rehospitalizations. A leading pulmonologist discusses evidence-based strategies for diagnosing COPD, managing exacerbations, and choosing from the many medication options when planning treatment.

 

MITIGATING STROKE RISK ACROSS THE CONTINUUM OF CARE: THE ROLE OF TARGETED ORAL ANTICOAGULANTS IN ATRIAL FIBRILLATION

This enduring on-demand CME webinar included didactic and case-based discussions presented in a roundtable format and involved experts from the specialties of cardiology, emergency medicine, primary care, and clinical pharmacy. The webinar was hosted on www.paradigmmc.com, and was promoted via several mechanisms, including a robust email campaign to Paradigm's internal database of learners and distribution through PeerAudience's OpenCME Network.

 

HOSPITALISTS ON THE FRONTLINE: PREVENTING AND MANAGING THROMBOEMBOLIC EVENTS

This live, interactive CME satellite symposium, presented at Hospital Medicine 2015, included didactic lectures, in-depth moderated Q&A between attendees and faculty, and patient education resources. An enduring web monograph developed from the proceedings features the most clinically relevant content and additional resources such as patient education materials. The interactive CME-certified web monograph is accessible via the Paradigm website, www.paradigmmc.com, the HQF website, and the website for The Hospitalist, www.the-hospitalist.org.

 

KEY UPDATES IN MANAGING ORAL ANTICOAGULATION AND ITS REVERSAL

This series of text- and audio-video-enabled CME/CPE-certified quarterly web newsletters will report on the latest developments in the field of thrombosis management, featuring summaries of important presentations at major medical conferences and embedded interviews with leading clinicians, researchers, and opinion leaders in the field of anticoagulation. These web newsletters will be accessible via the Paradigm website, www.paradigmmc.com, and the Hospital Quality Foundation (HQF) website, www.hospitalqualityfoundation.org and will be distributed quarterly by Paradigm, HQF, and Elsevier.

 

ANTICOAGULATION THERAPY IN PRIMARY CARE: KEEPING YOUR FINGER ON THE PULSE OF CURRENT CLINICAL RECOMMENDATIONS

Atrial fibrillation (AF) is the most common and important cardiac arrhythmia encountered in clinical practice. Even with the availability in recent years of 4 non-warfarin oral anticoagulants (NOACs), many at-risk patients are not assessed or treated appropriately due in part to confusion about where these agents fit in clinical practice. Due to pharmacodynamic and pharmacokinetic differences among the agents, patient-specific risk factors such as renal clearance must be taken into consideration when prescribing an NOAC. This activity has been designed to help primary care clinicians identify at-risk patients with AF, conduct an evidence-based work-up, and develop individualized treatment plans that appropriately utilize newer therapies when indicated.